TP53 and ovarian cancer: Since only one Nutlin-3a sensitive ovarian cancer cell line (A2780) with wild-type TP53 was available in the CCLE study, additional gene expression profiles for two Nutlin-3a sensitive cell lines (HOC-7 and OVCA429) identified in this study were generated to further delineate up-regulated genes that might be relevant to ovarian cancer cells.